Riskpilot← Back to searchSign inGet full accessTand i Surte AB
ABActiveOrg 5590885512Roslingsvägen 4Dental practice care activities · NACE 8623Est. 20165-9 employees
Revenue 2025
SEK 4,4M
+24% vs 2024
EBITDA margin
14.4%
+29% vs 2024
Equity ratio
63.9%
Financial strength
Net profit 2025
SEK 353K
+31% vs 2024
| Revenue | SEK 4,4M | +24% |
| EBITDA | SEK 641K | +29% |
| Net profit | SEK 353K | +31% |
| Total assets | SEK 2,6M | +14% |
| Equity | SEK 1,7M | +7% |
| Employees | — | — |
Legal name
Tand i Surte AB
Org number
5590885512
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
2 december 2016
Share capital
SEK 50 000
Employees
5-9
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva tandläkarverksamhet, sälja produkter som främjar tandhälsan samt därmed förenlig verksamhet. Bolaget ska även erbjuda estetiska och medicinska injektionsbehandlingar.
Address
Roslingsvägen 4
Email
setarehizadi@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 316 | 2 647 | 3 207 | 3 596 | 4 445 |
| Staff expenses | — | — | — | — | −2 161 |
| EBITDA | 278 | 92 | 574 | 497 | 641 |
| Depreciation & amort. | −31 | −36 | −31 | −31 | −31 |
| EBIT | 247 | 56 | 543 | 466 | 610 |
| Net financials | −3 | — | — | 1 | 0 |
| Profit before tax | 183 | 41 | 406 | 346 | 455 |
| Tax | −40 | −10 | −86 | −76 | 102 |
| Net profit | 143 | 31 | 320 | 270 | 353 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 729 | 1 751 | 2 130 | 2 276 | 2 593 |
| Equity | 1 184 | 1 215 | 1 535 | 1 555 | 1 658 |
| Long-term debt | 0 | 0 | 6 | 2 | 2 |
| Short-term debt | 244 | 220 | 135 | 146 | 205 |
| Total debt | 244 | 220 | 141 | 148 | 207 |
EBITDA margin
14.4%
This company
15.8%
Market median
-9% vs market
20212025
Equity ratio
63.9%
This company
38.2%
Market median
+67% vs market
20212025
Return on equity
21.3%
This company
18.4%
Market median
+16% vs market
20212025
Net profit margin
7.9%
This company
8.1%
Market median
-2% vs market
20212025
Asset turnover
1.71×
This company
1.12×
Market median
+53% vs market
20212025
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tand i Surte AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Setareh Izadi | Board of Directors | 0 companies |
| Omid Hakimi | Deputy Board Member | 0 companies |